Harshi Peiris: 2026 Cholesterol Guidelines Bring Earlier and More Precise Risk Assessment
Harshi Peiris, Science Writer and Communicator, shared JAMA‘s post on X:
“Big update in heart health:
The 2026 cholesterol guidelines just got a major overhaul – and it changes when doctors start checking your risk.
Dyslipidemia is when your blood fats (cholesterol, triglycerides) are out of healthy range, quietly raising your risk of heart attack and stroke.
New guidelines say: catch it earlier, test smarter, treat more precisely.
Have you had your cholesterol checked in the last year?”
JAMA shared a post on X about a recent article by Anum Saeed et al., adding:
“JAMA Clinical Guidelines Synopsis:
The 2026 Dyslipidemia guideline recommends lifetime measurement of Lp(a) in all adults and earlier ASCVD risk assessment with the PREVENT calculator starting at age 30.”
Title: Dyslipidemia Evaluation and Management
Authors: Anum Saeed, Andrew M. Davis, Amber E. Johnson

Stay updated on all scientific advances with Hemostasis Today.
-
Nov 20, 2026, 17:27Adam Bryant: Great Science, Valuable Connections and a Wonderful Haematology Community at Blood 2026
-
Nov 20, 2026, 17:25Gurpreet Kaurr: Scientific Discussions, New Perspectives and Inspiration at HAEMATOCON 2026
-
Nov 20, 2026, 17:24Bispecific FVIIIa-Mimetic Antibodies in Haemophilia A – CRH French Reference Center for Hemophilia Lyon
-
Nov 20, 2026, 17:23Khalid Rehman: Psychosocial Burden Among Caregivers of Patients with Beta-Thalassemia Major in Pakistan
-
Nov 20, 2026, 17:20Dhinesh Selvaraju: Caplacizumab Becomes the First FDA-Approved Treatment for Pediatric aTTP
-
Nov 20, 2026, 17:19Paris Margaritis: Presenting Preclinical Data on GENV-HEM at the WFH Workshop
-
Nov 20, 2026, 17:18WFH Opens Public Comment on Draft Guidelines for Hemostatic Agents and Prophylaxis
-
Nov 20, 2026, 17:18Ketan Asawale: Consensus on the Management of Cancer-Associated Thrombosis in India
-
Nov 20, 2026, 17:16Ajay Samkaria: The Evolution of Hemostasis Diagnostics with the ACL TOP 70 Series